V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Becton Dickinson & Co Executive Compensation (FY25)

BDX · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Thomas Polen
Latest say-on-pay support
=
January 27, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Becton Dickinson & Co brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 21, 2026Latest filing (8-K): January 30, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Becton Dickinson & Co brief$1,500Get the executive brief
Velarion Member, one year
337 figures on this page: 328 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Thomas Polen: $17,314,606 → $17,129,140 (1.1% lower)
Say-on-pay support: 89.0% → 91.4% (2.4 points higher)
CEO pay ratio: 396:1 → 374:1 (5.6% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Becton Dickinson & Co's chief executive and what were they paid?
Thomas Polen, Chairman, Chief Executive Officer and President, received $17,129,140 in total compensation for fiscal 2025. Compared with the $17,314,606 reported for fiscal 2024, Polen's total was 1.1% lower.
What was Becton Dickinson & Co's say-on-pay result?
The say-on-pay proposal drew 91.4% of votes cast for or against in favor at the meeting held January 27, 2026 for fiscal 2025.
Which companies are in Becton Dickinson & Co's peer group?
Companies named in the disclosed peer group include Abbott Laboratories, Agilent Technologies, Inc., Baxter International Inc., Boston Scientific Corporation and Danaher Corporation, among others.
What is Becton Dickinson & Co's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 374:1, against median employee compensation of $45,831.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman of the Board, Chief Executive Officer and President
◇—◇◇◇◇◇◇
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
◇◇◇◇◇—◇◇
Alberto Mas
Former Executive Vice President and President, Medical Segment
Departed during or after this year
◇◇◇◇◇◇◇◇
Samrat Khichi
Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs & General Counsel
◇—◇◇◇◇◇◇
David Hickey
Executive Vice President and President, Life Sciences Segment
◇—◇◇◇◇◇◇
Shana Neal
Executive Vice President and Chief People Officer
◇◇◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
◇—◇◇◇◇◇◇
Shana Neal
Executive Vice President and Chief People Officer
◇◇◇◇◇—◇◇
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
◇—◇◇◇◇◇◇
David Hickey
Executive Vice President and President, Life Sciences Segment
◇—◇◇◇◇◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
◇—◇◇◇◇◇◇
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
◇—◇◇◇◇◇◇
Shana Neal
Executive Vice President and Chief People Officer
◇—◇◇◇—◇◇
Richard Byrd
Executive Vice President and President, Interventional Segment
◇—◇◇◇◇◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas Polen
Chairman, Chief Executive Officer and President
◇—◇◇◇◇◇◇
Christopher DelOrefice
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Michael Feld
Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment
◇—◇◇◇—◇◇
Michael Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
◇—◇◇◇◇◇◇
Richard Byrd
Executive Vice President and President, Interventional Segment
◇—◇◇◇◇◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Christopher J. DelOreficeSAR◇——◇—◇◇
Christopher J. DelOreficeRSU◇——◇——◇
Christopher J. DelOreficePSU◇◇◇—◇—◇
Michael C. FeldSAR◇——◇—◇◇
Michael C. FeldPSU◇◇◇—◇—◇
Michael C. FeldRSU◇——◇——◇
Michael D. GarrisonSAR◇——◇—◇◇
Michael D. GarrisonRSU◇——◇——◇
Michael D. GarrisonPSU◇◇◇—◇—◇
Richard E. ByrdSAR◇——◇—◇◇
Richard E. ByrdRSU◇——◇——◇
Richard E. ByrdPSU◇◇◇—◇—◇
Thomas E. PolenPSU◇◇◇—◇—◇
Thomas E. PolenSAR◇——◇—◇◇
Thomas E. PolenRSU◇——◇——◇
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Richard ByrdSAR◇—◇11/26/2034
SAR◇—◇11/26/2032
SAR◇—◇11/26/2031
PSU◇◇——
RSU◇◇——
SAR◇—◇11/26/2033
Michael GarrisonRSU◇◇——
SAR◇—◇11/26/2032
SAR◇—◇11/26/2031
PSU◇◇——
SAR◇—◇11/26/2033
SAR◇—◇11/26/2034
Christopher DelOreficeRSU◇◇——
PSU◇◇——
SAR◇—◇11/26/2034
SAR◇—◇11/26/2032
SAR◇—◇11/26/2031
SAR◇—◇11/26/2033
Thomas PolenRSU◇◇——
SAR◇—◇11/26/2032
SAR◇—◇11/26/2034
SAR◇—◇11/26/2031
PSU◇◇——
SAR◇—◇11/26/2033
Michael FeldPSU◇◇——
RSU◇◇——
SAR◇—◇11/26/2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Bertram L. Scott
Lead independent director
◇◇————◇
R. Andrew Eckert
◇◇———◇◇
Christopher Jones
◇◇———◇◇
Catherine M. Burzik
◇◇————◇
Jeffrey W. Henderson
◇◇————◇
Carrie L. Byington
◇◇———◇◇
Claire M. Fraser
◇◇———◇◇
Joanne Waldstreicher
◇◇———◇◇
Timothy M. Ring
◇◇————◇
William M. Brown
◇◇————◇
Gregory J. Hayes
◇◇————◇
Thomas E. Polen, Jacqueline Wright and Robert L. Huffines served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Equity is delivered as restricted stock units.
Stock ownership guideline: 5x annual cash retainer ($600,000)

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Abbott Laboratories ABT
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Boston Scientific Corporation BSX
  • Danaher Corporation DHR
  • GE Healthcare Technologies, Inc. GEHC
  • Medtronic plc MDT
  • Stryker Corporation SYK
  • Thermo Fisher Scientific Inc. TMO
  • Zimmer Biomet Holdings, Inc. ZBH

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025January 27, 2026=◇◇◇
2024January 28, 2025=◇◇◇
2023January 23, 2024=◇◇◇
2022January 24, 2023=◇◇◇
2021January 25, 2022=◇◇◇
2020January 26, 2021=◇◇◇
2019January 28, 2020=◇◇◇
2018January 22, 2019=◇◇◇
2017January 23, 2018=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Thomas Polen (Chairman, Chief Executive Officer and President), FY2025 total compensation $17,129,140 (base salary $1,395,463) [exec_comp, SEC accession 0001628280-25-057846, filed 2025-12-18]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Becton Dickinson & Co files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Becton Dickinson & Co disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Becton Dickinson & Co sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Becton Dickinson & Co's disclosed peer group is defensible, who names Becton Dickinson & Co back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
337 figures on this page: 328 cited to the filing that reported them, 9 calculated from figures it prints.
328 cited to the filing
9 calculated from the filing

Documents cited

  1. 0001628280-26-004393
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001628280-25-057846
    CEO Pay Ratio · Fiscal 2025 director compensation · Fiscal year 2025 summary compensation table · Non-management director compensation · and 1 more section
  3. 0000010795-25-000011
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000010795-24-000096
    Fiscal year 2024 summary compensation table
  5. 0000010795-24-000006
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000010795-23-000118
    Fiscal year 2023 summary compensation table
  7. 0000010795-23-000015
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000010795-22-000084
  9. 0000010795-22-000007
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000010795-21-000019
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000010795-20-000003
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0000010795-19-000004
  13. 0001628280-18-000557
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Becton Dickinson & Co executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/BDX (accessed 2026).
Short form: data: Velarion

The Becton Dickinson & Co brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Becton Dickinson & Co and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Becton Dickinson & Co discloses

The companies named in BDX's own disclosed peer group.

Abbott LaboratoriesAgilent Technologies, Inc.Baxter International Inc.Boston Scientific CorporationDanaher CorporationGE Healthcare Technologies, Inc.Medtronic plcStryker CorporationThermo Fisher Scientific Inc.Zimmer Biomet Holdings, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy